The accreditors of this session require that you periodically check in to verify that you are still attentive. Please click the button below to indicate that you are.
An ISHLT 2020 Symposium Presentation
This session aims to review the evolving understanding of cardiogenic shock, including its varied presentations and trajectories, the importance of hemodynamic data in management, determination of treatment options, and the rapidly growing concept of multidisciplinary shock teams to deliver expedited and patient-centered care.
Scientific Program Agenda:
Shelley Hall, MD, FACC, FHFSA, FAST, Baylor University Medical Center, Dallas, TX, USA
Peter MacDonald, MD, PhD, St. Vincent’s Hospital, Sydney, Australia
Welcome, Symposium Overview
Kiran K. Khush, MD, Stanford University, Stanford, CA, USA
Liaison, ISHLT 2020 Program Committee Heart Group
From Code STEMI to Code Shock: Early Recognition is Key
Anique Ducharme, MD, MSc, Montreal Heart Institute, Montreal, QC, Canada
This talk will review the various phenotypes of cardiogenic shock and the new proposed shock categorization system. The importance of hemodynamics in shock recognition and treatment decision making will also be covered.
Let the Tissue Breathe: Use of Biomarkers to Optimize Organ Perfusion
Sandra Chaparro, MD, FACC, Miami Cardiac and Vascular Institute, Baptist Health South Florida, Miami, FL, USA
This talk reviews the best way to guide shock management from the blood-based biomarker point of view, in order to guide resuscitation strategies. This will include discussion of the comprehensive metabolic panel, lactate, troponin, and venous blood gas.
Drug Therapy for Cardiogenic Shock: Which, When, and How
Douglas Greig, MD, Pontificia Universidad Catolica de Chile, Santiago, Chile
The evidence for medical therapies as the initial basis for management of cardiogenic shock will be presented.
Teamwork Makes the Dream Work: Evolution of the Shock Team
Sharon Chih, MBBS, PhD, University of Ottawa Heart Institute, Ottawa, ON, Canada
This talk will discuss the development of shock teams, the structure of various programs, and their efficacy. The speaker will review tips and recommendations for best practices. How to choose the proper device for support within the shock team collaborative concept will also be covered.
Q & A segment with All Speakers
Led by Moderators
ISHLT Advanced Heart Failure and Transplantation Interdisciplinary Network Update
Marta Farrero Torres, MD, PhD, Hospital Clinic de Barcelona, Barcelona, Spain
Chair, Advanced Heart Failure and Transplantation Interdisciplinary Network Steering Committee
Greg Schultz, CEO, ISHLT, Addison, TX, USA
You must be logged in and own this session in order to post comments.